5 months ago
SRPT
AnalystsGil BlumGil Blum's Stock Forecasts
AnalystsGil Blum
Sectors:
Industries:
Analyst Ranking
Bottom 3%
#4763 out of 4867 analysts
Average Return
-3.13%
Win Rate
35%139 out of 392
Risk vs Reward
Poor
Good
Gil Blum's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mereo Biopharma Group PLCMREO | +364.14% | $0.71 | $3.30 | 2023-03-29 - 2024-03-28 | Buy |
Taysha Gene Therapies IncTSHA | +341.54% | $0.65 | $2.87 | 2023-03-28 - 2024-03-28 | Buy |
Nurix Therapeutics IncNRIX | +270.96% | $6.37 | $23.63 | 2023-10-12 - 2024-10-11 | Buy |
Cti Biopharma CorpCTIC | +267.07% | $1.64 | $6.02 | 2021-11-30 - 2022-11-30 | Buy |
Taysha Gene Therapies IncTSHA | +248.73% | $0.67 | $2.34 | 2023-05-11 - 2024-05-10 | Buy |
Gil Blum Analyst Color
Get additional color on Gil Blum's coverage of popular stocks
a year ago
AUTL
a year ago
AUTL
Gil Blum's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Celcuity IncCELC | 15 | Buy | $29.00 | +162.68% | Reiterates | 15 days ago |
Generation Bio CoGBIO | 16 | Buy | $8.00 | +1,800.24% | Reiterates | 16 days ago |
Taysha Gene Therapies IncTSHA | 26 | Buy | $6.00 | +229.67% | Reiterates | 16 days ago |
Autolus Therapeutics PLCAUTL | 27 | Buy | $10.00 | +614.29% | Reiterates | 16 days ago |
Immunocore Holdings PLCIMCR | 14 | Buy | $71.00 | +133.86% | Reiterates | 16 days ago |
Nurix Therapeutics IncNRIX | 23 | Buy | $27.00 | +134.38% | Maintains | 17 days ago |
Rocket Pharmaceuticals IncRCKT | 20 | Buy | $42.00 | +465.28% | Reiterates | 17 days ago |
Mereo Biopharma Group PLCMREO | 17 | Buy | $7.00 | +175.59% | Reiterates | 17 days ago |
Cartesian Therapeutics IncRNAC | 22 | Buy | $41.00 | +240.25% | Reiterates | 17 days ago |
Crispr Therapeutics AgCRSP | 20 | Buy | $84.00 | +114.78% | Reiterates | 17 days ago |
Nkarta IncNKTX | 15 | Buy | $11.00 | +400.00% | Reiterates | 17 days ago |
Absci CorpABSI | 3 | Buy | $9.00 | +179.50% | Reiterates | 17 days ago |
Tscan Therapeutics IncTCRX | 7 | Buy | $9.00 | +423.26% | Reiterates | 18 days ago |
Recursion Pharmaceuticals IncRXRX | 22 | Buy | $11.00 | +91.30% | Reiterates | 18 days ago |
Artiva Biotherapeutics IncARTV | 5 | Buy | $23.00 | +838.78% | Reiterates | 18 days ago |
I MabIMAB | 13 | Buy | $4.00 | +369.48% | Reiterates | 22 days ago |
Sarepta Therapeutics IncSRPT | 29 | Buy | $183.00 | +196.31% | Maintains | 23 days ago |
Geron CorpGERN | 22 | Buy | $5.00 | +252.11% | Reiterates | a month ago |
Arcellx IncACLX | 22 | Buy | $105.00 | +64.14% | Reiterates | 5 months ago |
Shattuck Labs IncSTTK | 13 | Hold | $8.00 | +854.65% | Downgrades | 7 months ago |
Nextcure IncNXTC | 9 | Buy | $4.00 | +854.65% | Reiterates | 9 months ago |
G1 Therapeutics IncGTHX | 17 | Buy | $6.00 | -16.08% | Maintains | 10 months ago |
Gamida Cell LtdGMDAQ | 8 | Buy | $6.00 | N/A | Reiterates | a year ago |
Cti Biopharma CorpCTIC | 5 | Buy | $9.00 | N/A | Reiterates | 2 years ago |
Tectonic Therapeutic IncTECX | 4 | Buy | $72.00 | N/A | Reiterates | 2 years ago |
Fate Therapeutics IncFATE | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Spyre Therapeutics IncSYRE | 1 | Buy | $225.00 | N/A | Maintains | 3 years ago |
Amicus Therapeutics IncFOLD | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.